STING agonist 8803 reprograms the immune microenvironment and increases survival in preclinical models of glioblastoma
STING激动剂8803可重塑免疫微环境,并提高胶质母细胞瘤临床前模型的生存率。
期刊:Journal of Clinical Investigation
影响因子:13.6
doi:10.1172/JCI175033
Najem, Hinda; Lea, Spencer T; Tripathi, Shashwat; Hurley, Lisa; Chen, Chao-Hsien; William, Ivana; Sooreshjani, Moloud; Bowie, Michelle; Hartley, Genevieve; Dussold, Corey; Pacheco, Sebastian; Dmello, Crismita; Lee-Chang, Catalina; McCortney, Kathleen; Steffens, Alicia; Walshon, Jordain; Ott, Martina; Wei, Jun; Marisetty, Anantha; Balyasnikova, Irina; Stupp, Roger; Lukas, Rimas V; Hu, Jian; James, Charles David; Horbinski, Craig M; Lesniak, Maciej S; Ashley, David M; Priebe, Waldemar; Platanias, Leonidas C; Curran, Michael A; Heimberger, Amy B